{"id":4734,"date":"2025-02-21T11:55:30","date_gmt":"2025-02-21T01:55:30","guid":{"rendered":"\/americas\/?p=4734"},"modified":"2026-03-03T15:51:00","modified_gmt":"2026-03-03T05:51:00","slug":"thailand-regulatory-application-for-remplir","status":"publish","type":"post","link":"\/americas\/thailand-regulatory-application-for-remplir\/","title":{"rendered":"Thailand Regulatory Application for Remplir\u2122"},"content":{"rendered":"

Orthocell has submitted a regulatory application to the FDA of Thailand to commence sales of its groundbreaking nerve repair device Remplir\u2122, with clearance expected in Q3 CY2025.<\/p>\n

This is an important milestone in our global expansion plans for Remplir\u2122, with the Thailand nerve repair market representing an $84M opportunity.<\/p>\n

Remplir is now gaining record sales traction in Australia, New Zealand and Singapore, with all sights set on US FDA clearance in March\/April 2025.<\/p>\n

Click to read the ASX Release.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Orthocell has submitted a regulatory application to the FDA of Thailand to commence sales of its groundbreaking nerve repair device Remplir\u2122, with clearance expected in Q3 CY2025.<\/p>\n","protected":false},"author":2,"featured_media":4736,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[21,2],"tags":[],"class_list":["post-4734","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-asx-announcements","category-company-news"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t